Europe Multiplex Assay Market 2024-2032

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,500	119 Pages	Triton Market Research	March, 2024	TRTN18685708

Best Price Guarantee
Price	from $1,500
Length	119 Pages
Publisher	Triton Market Research
Published Date	March, 2024
SKU	TRTN18685708

Europe Multiplex Assay Market 2024-2032

Market Outlook

Triton’s research estimates that the Europe multiplex assay market is set to progress at a CAGR of 8.17% during the 2024-2032 forecast years. The Netherlands, the United Kingdom, France, Italy, Spain, Germany, and the Rest of Europe are examined in this report.

The France multiplex assay market experiences notable influences from various factors, including advancements in the field, growth in genomics, and clinical trial developments. The escalation in chronic diseases, especially among the aging demographic, stands out as a significant catalyst. France observes a steady increase in its aging populace. Projections indicate the population of 65 and older to rise to approximately 25% by 2030. Notably, the segment aged 85 and above is anticipated to see even more rapid growth. This is significantly expected to create opportunities for the multiplex assay market.

Italy’s multiplex assay market is witnessing substantial growth, propelled by several factors, notably the escalating incidence of new cancer cases. In 2020, there were considerable numbers of new cancer cases reported, highlighting the pressing need for advanced diagnostic methodologies such as multiplex assays to enable early detection and intervention.

Competitive Outlook

The renowned companies in the multiple assay market comprise Illumina Inc, Abcam Limited, Bio-Rad Laboratories Inc, Becton, Dickson and Company, and Olink Proteomics AB.

1. Europe Multiplex Assay Market- Summary
2. Industry Outlook: 2.1. Impact Analysis On The Multiplex Assay Market; 2.1.1. Impact Of Covid-19 On The Multiplex Assay Market; 2.2. Porter’s Five Forces Model; 2.2.1. Threat Of New Entrants; 2.2.2. Threat Of Substitute Products; 2.2.3. Bargaining Power Of Buyers; 2.2.4. Bargaining Power Of Suppliers; 2.2.5. Competitive Rivalry; 2.3. Key Buying Impact Analysis; 2.3.1. Analyte Coverage; 2.3.2. Speed; 2.3.3. Multiplexing Capability; 2.3.4. Ease Of Use; 2.3.5. Automation; 2.4. Market Attractiveness Index; 2.5. Key Market Strategies; 2.5.1. Contracts And Partnerships; 2.5.2. Business Expansions & Divestitures; 2.5.3. Acquisitions & Mergers; 2.5.4. Product Launches & Developments; 2.6. Market Drivers; 2.6.1. Adoption Of Personalized Medicines; 2.6.2. High Adoption Of Multiplex Assays Over Traditional Methods; 2.6.3. Increasing Prevalence Of Chronic Diseases; 2.7. Market Challenges; 2.7.1. Issues Related To Cross-reactivity And Assay Interference; 2.7.2. Challenge In Achieving Adequate Assay Range; 2.7.3. Dearth Of Skilled Professionals; 2.8. Market Opportunities; 2.8.1. Technological Advancements In Assay Platforms; 2.8.2. Rapid Growth Of Companion Diagnostics; 2.8.3. Growth In Drug Discovery Initiatives; 2.9. Analyst Perspective
3. Europe Multiplex Assay Market - By Product And Service: 3.1. Reagents And Consumables; 3.2. Instruments And Accessories; 3.3. Software And Services
4. Europe Multiplex Assay Market - By Type: 4.1. Protein-based Multiplex Assay; 4.2. Nucleic Acid-based Multiplex Assay; 4.3. Other Multiplex Assays
5. Europe Multiplex Assay Market - By Application: 5.1. Research And Development; 5.2. Clinical Diagnostics; 5.3. Companion Diagnostics
6. Europe Multiplex Assay Market - By Technology: 6.1. Multiplex Protein Microarray; 6.2. Multiplex Pcr; 6.3. Other Technologies
7. Europe Multiplex Assay Market - By Industry Vertical: 7.1. Pharmaceutical & Biotechnology Companies; 7.2. Research Institutes; 7.3. Clinical Laboratories; 7.4. Hospitals
8. Europe Multiplex Assay Market – By Country Outlook: 8.1. Germany; 8.1.1. Germany Multiplex Assay Market Forecast & Prospects; 8.2. United Kingdom; 8.2.1. United Kingdom Multiplex Assay Market Forecast & Prospects; 8.3. France; 8.3.1. France Multiplex Assay Market Forecast & Prospects; 8.4. Italy; 8.4.1. Italy Market Forecast & Prospects; 8.5. Spain; 8.5.1. Spain Multiplex Assay Market Forecast & Prospects; 8.6. Netherlands; 8.6.1. Netherlands Multiplex Assay Market Forecast & Prospects; 8.7. Rest Of Europe; 8.7.1. Rest Of Europe Multiplex Assay Market Forecast & Prospects
9. Competitive Landscape: 9.1. Abcam Limited; 9.1.1. Overview; 9.1.2. Product Portfolio; 9.2. Agilent Technologies Inc; 9.2.1. Overview; 9.2.2. Product Portfolio; 9.2.3. Key Strengths; 9.2.4. Key Challenges; 9.3. Becton Dickinson And Company (Bd); 9.3.1. Overview; 9.3.2. Product Portfolio; 9.3.3. Key Strengths; 9.3.4. Key Challenges; 9.4. Bio-rad Laboratories Inc; 9.4.1. Overview; 9.4.2. Product Portfolio; 9.4.3. Key Strengths; 9.4.4. Key Challenges; 9.5. Bio-techne Corporation; 9.5.1. Overview; 9.5.2. Product Portfolio; 9.6. F. Hoffmann-la Roche Ltd; 9.6.1. Overview; 9.6.2. Product Portfolio; 9.6.3. Key Strengths; 9.6.4. Key Challenges; 9.7. Illumina Inc; 9.7.1. Overview; 9.7.2. Product Portfolio; 9.7.3. Key Strengths; 9.7.4. Key Challenges; 9.8. Merck Millipore; 9.8.1. Overview; 9.8.2. Product Portfolio; 9.9. Olink Proteomics Ab; 9.9.1. Overview; 9.9.2. Product Portfolio; 9.10. Qiagen Nv; 9.10.1. Overview; 9.10.2. Product Portfolio; 9.10.3. Key Strengths; 9.10.4. Key Challenges; 9.11. Randox Laboratories Ltd; 9.11.1. Overview; 9.11.2. Product Portfolio; 9.12. Seegene Inc; 9.12.1. Overview; 9.12.2. Product Portfolio; 9.13. Siemens Healthineers Ag; 9.13.1. Overview; 9.13.2. Product Portfolio; 9.13.3. Key Strengths; 9.13.4. Key Challenges; 9.14. Thermo Fisher Scientific Inc; 9.14.1. Overview; 9.14.2. Product Portfolio; 9.14.3. Key Strengths; 9.14.4. Key Challenges
10. Research Methodology & Scope: 10.1. Research Scope & Deliverables; 10.2. Sources Of Data; 10.3. Research Methodology
List Of Tables: Table 1: Europe Multiplex Assay Market, By Country Outlook, Historical Years, 2020-2023 (In $ Million); Table 2: Europe Multiplex Assay Market, By Country Outlook, Forecast Years, 2024-2032 (In $ Million); Table 3: Contracts And Partnerships; Table 4: List Of Business Expansions & Divestitures; Table 5: Acquisitions & Mergers; Table 6: List Of New Product Launches & Developments; Table 7: Europe Multiplex Assay Market, By Product And Service, 2024-2032 (In $ Million); Table 8: Europe Multiplex Assay Market, By Type, 2024-2032 (In $ Million); Table 9: Europe Multiplex Assay Market, By Application, 2024-2032 (In $ Million); Table 10: Europe Multiplex Assay Market, By Technology, 2024-2032 (In $ Million); Table 11: Europe Multiplex Assay Market, By Industry Vertical, 2024-2032 (In $ Million); Table 12: Europe Multiplex Assay Market, By Country Outlook, 2024-2032 (In $ Million)
List Of Figures: Figure 1: Europe Multiplex Assay Market, By Product And Service, 2023 & 2032 (In %); Figure 2: Europe Multiplex Assay Market, By Reagents And Consumables, 2024-2032 (In $ Million); Figure 3: Europe Multiplex Assay Market, By Instruments And Accessories, 2024-2032 (In $ Million); Figure 4: Europe Multiplex Assay Market, By Software And Services, 2024-2032 (In $ Million); Figure 5: Europe Multiplex Assay Market, By Type, 2023 & 2032 (In %); Figure 6: Europe Multiplex Assay Market, By Protein-based Multiplex Assay, 2024-2032 (In $ Million); Figure 7: Europe Multiplex Assay Market, By Nucleic Acid-based Multiplex Assay, 2024-2032 (In $ Million); Figure 8: Europe Multiplex Assay Market, By Other Multiplex Assays, 2024-2032 (In $ Million); Figure 9: Europe Multiplex Assay Market, By Application, 2023 & 2032 (In %); Figure 10: Europe Multiplex Assay Market, By Research And Development, 2024-2032 (In $ Million); Figure 11: Europe Multiplex Assay Market, By Clinical Diagnostics, 2024-2032 (In $ Million); Figure 12: Europe Multiplex Assay Market, By Companion Diagnostics, 2024-2032 (In $ Million); Figure 13: Europe Multiplex Assay Market, By Technology, 2023 & 2032 (In %); Figure 14: Europe Multiplex Assay Market, By Multiplex Protein Microarray, 2024-2032 (In $ Million); Figure 15: Europe Multiplex Assay Market, By Multiplex Pcr, 2024-2032 (In $ Million); Figure 16: Europe Multiplex Assay Market, By Other Technologies, 2024-2032 (In $ Million); Figure 17: Europe Multiplex Assay Market, By Industry Verticals, 2023 & 2032 (In %); Figure 18: Europe Multiplex Assay Market, By Pharmaceutical & Biotechnology Companies, 2024-2032 (In $ Million); Figure 19: Europe Multiplex Assay Market, By Research Institutes, 2024-2032 (In $ Million); Figure 20: Europe Multiplex Assay Market, By Clinical Laboratories, 2024-2032 (In $ Million); Figure 21: Europe Multiplex Assay Market, By Hospitals, 2024-2032 (In $ Million); Figure 22: Europe Multiplex Assay Market, By Country Outlook, 2023 & 2032 (In %); Figure 23: Germany Multiplex Assay Market 2024-2032 (In $ Million); Figure 24: United Kingdom Multiplex Assay Market 2024-2032 (In $ Million); Figure 25: France Multiplex Assay Market 2024-2032 (In $ Million); Figure 26: Italy Multiplex Assay Market 2024-2032 (In $ Million); Figure 27: Spain Multiplex Assay Market 2024-2032 (In $ Million); Figure 28: Netherlands Multiplex Assay Market 2024-2032 (In $ Million); Figure 29: Rest Of Europe Multiplex Assay Market 2024-2032 (In $ Million)